Nureca Technologies Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 Cr
as on 16-11-2024
- Revenue 4329.40%
(FY 2023)
- Profit 220.50%
(FY 2023)
- Ebitda 394.22%
(FY 2023)
- Net Worth 247.74%
(FY 2023)
- Total Assets 287.35%
(FY 2023)
About Nureca Technologies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹5.50 Cr.
Saurabh Goyal, Rajinder Sharma, and Aryan Goyal serve as directors at the Company.
- CIN/LLPIN
U33110PB2020PTC051368
- Company No.
051368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2020
- Date of AGM
31 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Nureca Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aryan Goyal  | Director | 27-Sep-2021 | Current |
| Saurabh Goyal | Director | 21-Oct-2020 | Current |
| Rajinder Sharma | Director | 31-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Nureca Technologies.
Nureca Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4329.4% increase. The company also saw a substantial improvement in profitability, with a 220.5% increase in profit. The company's net worth Soared by an impressive increase of 247.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nureca Technologies?
In 2023, Nureca Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nureca Healthcare Private LimitedActive 4 years 4 monthsSaurabh Goyal, Rajinder Sharma and 1 more are mutual person
Nectar Biopharma Private LimitedActive 9 years 8 monthsSaurabh Goyal, Rajinder Sharma and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 May 2024 | ₹5.50 Cr | Open |
How Many Employees Work at Nureca Technologies?
Nureca Technologies has a workforce of 15 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nureca Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nureca Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
